Close Menu

QuantumDx

John Burn has been appointed as a non-executive director of NHS England, QuantuMDx said this week.

NEW YORK (GenomeWeb) — QuantuMDx will use the proceeds from a recent financing round to optimize its handheld Q-POC molecular diagnostic device as well as several assays ahead of planned launches in 2015 and 2016.

NEW YORK (GenomeWeb News) – British molecular diagnostics company QuantuMDx has closed an $8.4 million investment round to further the development of a device for point-of-care testing, the firm said today.

NEW YORK (GenomeWeb News) – The Singapore Institute of Manufacturing Technology announced today a deal with QuantuMDx in support of the UK firm's development of a handheld point-of-care molecular diagnostic device.

NEW YORK (GenomeWeb News) – After years in development, a handheld point-of-care molecular diagnostic device from QuantuMDx is poised to hit the market next year with malaria and tuberculosis as its initial target markets, a company executive said last week on the sidelines of the 32nd Annual JP

QuantumDx CEO Elaine Warburton is being recognized for her work in the molecular diagnostics field and being dubbed an Officer of the Order of the British Empire.

QuantumDx CEO Elaine Warburton will become an Officer of the Order of the British Empire, the Newcastle, UK-based molecular diagnostics firm announced recently.

QuantumDx CEO Elaine Warburton will become an Officer of the Order of the British Empire, the Newcastle, UK-based molecular diagnostics firm announced recently.

NEW YORK (GenomeWeb News) – QuantuMDx said today that its subsidiary NorthGene has received accreditation from the UK's Ministry of Justice to perform legal DNA tests for parentage.

This story has been updated to clarify that QuantumDx has not yet invested in Pastel Bioscience.
UK-based biotech firm Pastel BioScience is building an array-based proteomics platform with the aim of accessing the entire human proteome.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.